GB202119115D0 - Vaccine - Google Patents

Vaccine

Info

Publication number
GB202119115D0
GB202119115D0 GBGB2119115.0A GB202119115A GB202119115D0 GB 202119115 D0 GB202119115 D0 GB 202119115D0 GB 202119115 A GB202119115 A GB 202119115A GB 202119115 D0 GB202119115 D0 GB 202119115D0
Authority
GB
United Kingdom
Prior art keywords
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2119115.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fondo Ricerca Medica Srl
Original Assignee
Fondo Ricerca Medica Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fondo Ricerca Medica Srl filed Critical Fondo Ricerca Medica Srl
Priority to GBGB2119115.0A priority Critical patent/GB202119115D0/en
Publication of GB202119115D0 publication Critical patent/GB202119115D0/en
Priority to PCT/EP2022/087715 priority patent/WO2023126343A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20071—Demonstrated in vivo effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB2119115.0A 2021-12-30 2021-12-30 Vaccine Ceased GB202119115D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2119115.0A GB202119115D0 (en) 2021-12-30 2021-12-30 Vaccine
PCT/EP2022/087715 WO2023126343A1 (en) 2021-12-30 2022-12-23 Mrna vaccine against variants of sars-cov-2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2119115.0A GB202119115D0 (en) 2021-12-30 2021-12-30 Vaccine

Publications (1)

Publication Number Publication Date
GB202119115D0 true GB202119115D0 (en) 2022-02-16

Family

ID=80220011

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2119115.0A Ceased GB202119115D0 (en) 2021-12-30 2021-12-30 Vaccine

Country Status (2)

Country Link
GB (1) GB202119115D0 (en)
WO (1) WO2023126343A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016118724A1 (en) 2015-01-21 2016-07-28 Moderna Therapeutics, Inc. Lipid nanoparticle compositions
WO2016118725A1 (en) 2015-01-23 2016-07-28 Moderna Therapeutics, Inc. Lipid nanoparticle compositions
EP4147717A1 (en) * 2020-02-04 2023-03-15 CureVac SE Coronavirus vaccine
EP4103228A1 (en) * 2020-02-13 2022-12-21 Institut Pasteur Nucleic acid vaccine against the sars-cov-2 coronavirus
US20230248819A1 (en) * 2020-06-11 2023-08-10 Daiichi Sankyo Company, Limited Nucleic acid lipid particle vaccine

Also Published As

Publication number Publication date
WO2023126343A1 (en) 2023-07-06

Similar Documents

Publication Publication Date Title
GB202010425D0 (en) Combination vaccine
GB202002166D0 (en) Vaccine
EP4213872A4 (en) Piv5-based covid-19 vaccine
IL292272A (en) Cancer vaccine
IL288673A (en) Tgf-beta vaccine
GB201910794D0 (en) Vaccine
GB202016954D0 (en) Vaccine
GB201811382D0 (en) Vaccine
GB202119115D0 (en) Vaccine
GB202118110D0 (en) Vaccine
GB202114274D0 (en) SARS-CoV-2 vaccine
GB202112149D0 (en) Shigellla vaccine
GB202102677D0 (en) Vaccine
GB202016165D0 (en) Vaccine
GB202014719D0 (en) Vaccine
GB202013534D0 (en) Vaccine
GB202013541D0 (en) Vaccine
GB202013253D0 (en) Vaccine
GB202009402D0 (en) Vaccine
GB202005880D0 (en) Vaccine
GB202005878D0 (en) Vaccine
GB202003292D0 (en) Vaccine
GB202003289D0 (en) Vaccine
IL311439A (en) Pancoronavirus vaccines
GB202116831D0 (en) Vaccines

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)